Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1989 May;63(5):2143–2151. doi: 10.1128/jvi.63.5.2143-2151.1989

Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.

B Baxt 1, V Vakharia 1, D M Moore 1, A J Franke 1, D O Morgan 1
PMCID: PMC250631  PMID: 2467993

Abstract

A series of seven neutralizing monoclonal antibodies (nMAbs) directed against type A12 foot-and-mouth disease virus was used to generate neutralization-resistant variants. Both plaque reduction neutralization and microneutralization assays showed that the variants were no longer neutralized by the nMAbs used to generate them, although some of the variants still reacted with the nMAbs at high antibody concentrations. Results of cross-neutralization studies by both plaque reduction neutralization and microneutralization assays suggested the presence of at least one immunodominant antigenic site on the surface of type A12 foot-and-mouth disease virus, along with evidence of a second antigenic site on the viral surface. Two of the variants had reduced virulence in tissue culture as evidenced by their inability to inhibit cellular protein synthesis and a marked reduction in virus-induced cellular morphological alterations. Nucleotide sequencing of the variant genomes placed three epitopes of the major antigenic site on VP1 and the fourth epitope on VP3 and VP1. The one epitope of the minor site appears to reside only on VP1.

Full text

PDF
2143

Images in this article

2147Image
on p.2147
2147Image
on p.2147

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agol V. I., Drozdov S. G., Frolova M. P., Grachev V. P., Kolesnikova M. S., Kozlov V. G., Ralph N. M., Romanova L. I., Tolskaya E. A., Viktorova E. G. Neurovirulence of the intertypic poliovirus recombinant v3/a1-25: characterization of strains isolated from the spinal cord of diseased monkeys and evaluation of the contribution of the 3' half of the genome. J Gen Virol. 1985 Feb;66(Pt 2):309–316. doi: 10.1099/0022-1317-66-2-309. [DOI] [PubMed] [Google Scholar]
  2. Agol V. I., Drozdov S. G., Grachev V. P., Kolesnikova M. S., Kozlov V. G., Ralph N. M., Romanova L. I., Tolskaya E. A., Tyufanov A. V., Viktorova E. G. Recombinants between attenuated and virulent strains of poliovirus type 1: derivation and characterization of recombinants with centrally located crossover points. Virology. 1985 Jun;143(2):467–477. doi: 10.1016/0042-6822(85)90386-1. [DOI] [PubMed] [Google Scholar]
  3. Bachrach H. L., Moore D. M., McKercher P. D., Polatnick J. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J Immunol. 1975 Dec;115(6):1636–1641. [PubMed] [Google Scholar]
  4. Bachrach H. L., Morgan D. O., McKercher P. D., Moore D. M., Robertson B. H. Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP and of virus containing cleaved VP. Vet Microbiol. 1982 May;7(2):85–96. doi: 10.1016/0378-1135(82)90020-7. [DOI] [PubMed] [Google Scholar]
  5. Bachrach H. L., Morgan D. O., Moore D. M. Foot-and-mouth disease virus immunogenic capsid protein VPT: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavages. Intervirology. 1979;12(2):65–72. doi: 10.1159/000149070. [DOI] [PubMed] [Google Scholar]
  6. Baxt B., Bachrach H. L. Early interactions of foot-and-mouth disease virus with cultured cells. Virology. 1980 Jul 15;104(1):42–55. doi: 10.1016/0042-6822(80)90364-5. [DOI] [PubMed] [Google Scholar]
  7. Baxt B., Bachrach H. L. The adsorption and degradation of foot-and-mouth disease virus by isolated BHK-21 cell plasma membranes. Virology. 1982 Jan 30;116(2):391–405. doi: 10.1016/0042-6822(82)90134-9. [DOI] [PubMed] [Google Scholar]
  8. Baxt B. Effect of lysosomotropic compounds on early events in foot-and-mouth disease virus replication. Virus Res. 1987 May;7(3):257–271. doi: 10.1016/0168-1702(87)90032-3. [DOI] [PubMed] [Google Scholar]
  9. Baxt B., Morgan D. O., Robertson B. H., Timpone C. A. Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment. J Virol. 1984 Aug;51(2):298–305. doi: 10.1128/jvi.51.2.298-305.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature. 1982 Jul 1;298(5869):30–33. doi: 10.1038/298030a0. [DOI] [PubMed] [Google Scholar]
  11. Blaas D., Kuechler E., Vriend G., Arnold E., Luo M., Rossmann M. G. Comparison of the three-dimensional structure of two human rhinoviruses (HRV2 and HRV14). Proteins. 1987;2(4):263–272. doi: 10.1002/prot.340020402. [DOI] [PubMed] [Google Scholar]
  12. Blondel B., Crainic R., Fichot O., Dufraisse G., Candrea A., Diamond D., Girard M., Horaud F. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J Virol. 1986 Jan;57(1):81–90. doi: 10.1128/jvi.57.1.81-90.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cann A. J., Stanway G., Hughes P. J., Minor P. D., Evans D. M., Schild G. C., Almond J. W. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine. Nucleic Acids Res. 1984 Oct 25;12(20):7787–7792. doi: 10.1093/nar/12.20.7787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chow M., Newman J. F., Filman D., Hogle J. M., Rowlands D. J., Brown F. Myristylation of picornavirus capsid protein VP4 and its structural significance. Nature. 1987 Jun 11;327(6122):482–486. doi: 10.1038/327482a0. [DOI] [PubMed] [Google Scholar]
  15. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science. 1986 May 2;232(4750):639–641. doi: 10.1126/science.3008333. [DOI] [PubMed] [Google Scholar]
  16. Diamond D. C., Jameson B. A., Bonin J., Kohara M., Abe S., Itoh H., Komatsu T., Arita M., Kuge S., Nomoto A. Antigenic variation and resistance to neutralization in poliovirus type 1. Science. 1985 Sep 13;229(4718):1090–1093. doi: 10.1126/science.2412292. [DOI] [PubMed] [Google Scholar]
  17. Evans D. M., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V., Jr Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature. 1985 Apr 11;314(6011):548–550. doi: 10.1038/314548a0. [DOI] [PubMed] [Google Scholar]
  18. Evans D. M., Minor P. D., Schild G. S., Almond J. W. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature. 1983 Aug 4;304(5925):459–462. doi: 10.1038/304459a0. [DOI] [PubMed] [Google Scholar]
  19. Fox G., Stuart D., Acharya K. R., Fry E., Rowlands D., Brown F. Crystallization and preliminary X-ray diffraction analysis of foot-and-mouth disease virus. J Mol Biol. 1987 Aug 5;196(3):591–597. doi: 10.1016/0022-2836(87)90035-0. [DOI] [PubMed] [Google Scholar]
  20. Gebauer F., de la Torre J. C., Gomes I., Mateu M. G., Barahona H., Tiraboschi B., Bergmann I., de Mello P. A., Domingo E. Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. J Virol. 1988 Jun;62(6):2041–2049. doi: 10.1128/jvi.62.6.2041-2049.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Grubman M. J., Baxt B. Translation of foot-and-mouth disease virion RNA and processing of the primary cleavage products in a rabbit reticulocyte lysate. Virology. 1982 Jan 15;116(1):19–30. doi: 10.1016/0042-6822(82)90399-3. [DOI] [PubMed] [Google Scholar]
  22. Grubman M. J., Morgan D. O. Antigenic comparison of foot-and-mouth disease virus serotypes with monoclonal antibodies. Virus Res. 1986 Oct;6(1):33–43. doi: 10.1016/0168-1702(86)90055-9. [DOI] [PubMed] [Google Scholar]
  23. Grubman M. J., Morgan D. O., Kendall J., Baxt B. Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells. J Virol. 1985 Oct;56(1):120–126. doi: 10.1128/jvi.56.1.120-126.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hogle J. M., Chow M., Filman D. J. Three-dimensional structure of poliovirus at 2.9 A resolution. Science. 1985 Sep 27;229(4720):1358–1365. doi: 10.1126/science.2994218. [DOI] [PubMed] [Google Scholar]
  25. Kleid D. G., Yansura D., Small B., Dowbenko D., Moore D. M., Grubman M. J., McKercher P. D., Morgan D. O., Robertson B. H., Bachrach H. L. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science. 1981 Dec 4;214(4525):1125–1129. doi: 10.1126/science.6272395. [DOI] [PubMed] [Google Scholar]
  26. Lo K. M., Jones S. S., Hackett N. R., Khorana H. G. Specific amino acid substitutions in bacterioopsin: Replacement of a restriction fragment in the structural gene by synthetic DNA fragments containing altered codons. Proc Natl Acad Sci U S A. 1984 Apr;81(8):2285–2289. doi: 10.1073/pnas.81.8.2285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Luo M., Rossmann M. G., Palmenberg A. C. Prediction of three-dimensional models for foot-and-mouth disease virus and hepatitis A virus. Virology. 1988 Oct;166(2):503–514. doi: 10.1016/0042-6822(88)90521-1. [DOI] [PubMed] [Google Scholar]
  28. Martinez M. A., Carrillo C., Plana J., Mascarella R., Bergada J., Palma E. L., Domingo E., Sobrino F. Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus. Gene. 1988;62(1):75–84. doi: 10.1016/0378-1119(88)90581-1. [DOI] [PubMed] [Google Scholar]
  29. McCullough K. C., Crowther J. R., Carpenter W. C., Brocchi E., Capucci L., De Simone F., Xie Q., McCahon D. Epitopes on foot-and-mouth disease virus particles. I. Topology. Virology. 1987 Apr;157(2):516–525. doi: 10.1016/0042-6822(87)90294-7. [DOI] [PubMed] [Google Scholar]
  30. Meloen R. H., Barteling S. J. An epitope located at the C terminus of isolated VP1 of foot-and-mouth disease virus type O induces neutralizing activity but poor protection. J Gen Virol. 1986 Feb;67(Pt 2):289–294. doi: 10.1099/0022-1317-67-2-289. [DOI] [PubMed] [Google Scholar]
  31. Meloen R. H., Barteling S. J. Epitope mapping of the outer structural protein VP1 of three different serotypes of foot-and-mouth disease virus. Virology. 1986 Feb;149(1):55–63. doi: 10.1016/0042-6822(86)90086-3. [DOI] [PubMed] [Google Scholar]
  32. Meloen R. H., Puyk W. C., Meijer D. J., Lankhof H., Posthumus W. P., Schaaper W. M. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus. J Gen Virol. 1987 Feb;68(Pt 2):305–314. doi: 10.1099/0022-1317-68-2-305. [DOI] [PubMed] [Google Scholar]
  33. Mills D. R., Kramer F. R. Structure-independent nucleotide sequence analysis. Proc Natl Acad Sci U S A. 1979 May;76(5):2232–2235. doi: 10.1073/pnas.76.5.2232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Minor P. D., Evans D. M., Ferguson M., Schild G. C., Westrop G., Almond J. W. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. J Gen Virol. 1985 May;66(Pt 5):1159–1165. doi: 10.1099/0022-1317-66-5-1159. [DOI] [PubMed] [Google Scholar]
  35. Minor P. D., Schild G. C., Bootman J., Evans D. M., Ferguson M., Reeve P., Spitz M., Stanway G., Cann A. J., Hauptmann R. Location and primary structure of a major antigenic site for poliovirus neutralization. Nature. 1983 Feb 24;301(5902):674–679. doi: 10.1038/301674a0. [DOI] [PubMed] [Google Scholar]
  36. Morrell D. J., Mellor E. J., Rowlands D. J., Brown F. Surface structure and RNA-protein interactions of foot-and-mouth disease virus. J Gen Virol. 1987 Jun;68(Pt 6):1649–1658. doi: 10.1099/0022-1317-68-6-1649. [DOI] [PubMed] [Google Scholar]
  37. Page G. S., Mosser A. G., Hogle J. M., Filman D. J., Rueckert R. R., Chow M. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol. 1988 May;62(5):1781–1794. doi: 10.1128/jvi.62.5.1781-1794.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Parisi J. M., Costa Giomi P., Grigera P., Augé de Mello P., Bergmann I. E., La Torre J. L., Scodeller E. A. Biochemical characterization of an aphthovirus type 0(1) strain campos attenuated for cattle by serial passages in chicken embryos. Virology. 1985 Nov;147(1):61–71. doi: 10.1016/0042-6822(85)90227-2. [DOI] [PubMed] [Google Scholar]
  39. Pfaff E., Thiel H. J., Beck E., Strohmaier K., Schaller H. Analysis of neutralizing epitopes on foot-and-mouth disease virus. J Virol. 1988 Jun;62(6):2033–2040. doi: 10.1128/jvi.62.6.2033-2040.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Prabhakar B. S., Srinivasappa J., Ray U. Selection of coxsackievirus B4 variants with monoclonal antibodies results in attenuation. J Gen Virol. 1987 Mar;68(Pt 3):865–869. doi: 10.1099/0022-1317-68-3-865. [DOI] [PubMed] [Google Scholar]
  41. Robertson B. H., Grubman M. J., Weddell G. N., Moore D. M., Welsh J. D., Fischer T., Dowbenko D. J., Yansura D. G., Small B., Kleid D. G. Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol. 1985 Jun;54(3):651–660. doi: 10.1128/jvi.54.3.651-660.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Robertson B. H., Moore D. M., Grubman M. J., Kleid D. G. Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus. J Virol. 1983 Apr;46(1):311–316. doi: 10.1128/jvi.46.1.311-316.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Robertson B. H., Morgan D. O., Moore D. M. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12. Virus Res. 1984 Sep;1(6):489–500. doi: 10.1016/0168-1702(84)90006-6. [DOI] [PubMed] [Google Scholar]
  44. Rossmann M. G., Arnold E., Erickson J. W., Frankenberger E. A., Griffith J. P., Hecht H. J., Johnson J. E., Kamer G., Luo M., Mosser A. G. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature. 1985 Sep 12;317(6033):145–153. doi: 10.1038/317145a0. [DOI] [PubMed] [Google Scholar]
  45. Rowlands D. J., Clarke B. E., Carroll A. R., Brown F., Nicholson B. H., Bittle J. L., Houghten R. A., Lerner R. A. Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature. 1983 Dec 15;306(5944):694–697. doi: 10.1038/306694a0. [DOI] [PubMed] [Google Scholar]
  46. Sagedahl A., Giraudo A. T., De Mello P. A., Bergmann I. E., La Torre J. L., Scodeller E. A. Biochemical characterization of an aphthovirus type C3 strain Resende attenuated for cattle by serial passages in chicken embryos. Virology. 1987 Apr;157(2):366–374. doi: 10.1016/0042-6822(87)90279-0. [DOI] [PubMed] [Google Scholar]
  47. Sherry B., Mosser A. G., Colonno R. J., Rueckert R. R. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J Virol. 1986 Jan;57(1):246–257. doi: 10.1128/jvi.57.1.246-257.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sherry B., Rueckert R. Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J Virol. 1985 Jan;53(1):137–143. doi: 10.1128/jvi.53.1.137-143.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sobrino F., Dávila M., Ortín J., Domingo E. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology. 1983 Jul 30;128(2):310–318. doi: 10.1016/0042-6822(83)90258-1. [DOI] [PubMed] [Google Scholar]
  50. Sobrino F., Palma E. L., Beck E., Dávila M., de la Torre J. C., Negro P., Villanueva N., Ortín J., Domingo E. Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene. 1986;50(1-3):149–159. doi: 10.1016/0378-1119(86)90320-3. [DOI] [PubMed] [Google Scholar]
  51. Stapleton J. T., Lemon S. M. Neutralization escape mutants define a dominant immunogenic neutralization site on hepatitis A virus. J Virol. 1987 Feb;61(2):491–498. doi: 10.1128/jvi.61.2.491-498.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Stave J. W., Card J. L., Morgan D. O. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies. J Gen Virol. 1986 Oct;67(Pt 10):2083–2092. doi: 10.1099/0022-1317-67-10-2083. [DOI] [PubMed] [Google Scholar]
  53. Stave J. W., Card J. L., Morgan D. O., Vakharia V. N. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants. Virology. 1988 Jan;162(1):21–29. doi: 10.1016/0042-6822(88)90390-x. [DOI] [PubMed] [Google Scholar]
  54. Strohmaier K., Franze R., Adam K. H. Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol. 1982 Apr;59(Pt 2):295–306. doi: 10.1099/0022-1317-59-2-295. [DOI] [PubMed] [Google Scholar]
  55. Thomas A. A., Woortmeijer R. J., Puijk W., Barteling S. J. Antigenic sites on foot-and-mouth disease virus type A10. J Virol. 1988 Aug;62(8):2782–2789. doi: 10.1128/jvi.62.8.2782-2789.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Trautman R., Harris W. F. Modeling and computer stimulation approach to the mechanism of foot-and-mouth disease virus neutralization assays. Scand J Immunol. 1977;6(8):831–841. doi: 10.1111/j.1365-3083.1977.tb02158.x. [DOI] [PubMed] [Google Scholar]
  57. Wiegers K., Uhlig H., Dernick R. Evidence for a complex structure of neutralization antigenic site I of poliovirus type 1 Mahoney. J Virol. 1988 May;62(5):1845–1848. doi: 10.1128/jvi.62.5.1845-1848.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Xie Q. C., McCahon D., Crowther J. R., Belsham G. J., McCullough K. C. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol. 1987 Jun;68(Pt 6):1637–1647. doi: 10.1099/0022-1317-68-6-1637. [DOI] [PubMed] [Google Scholar]
  59. de la Torre J. C., Martínez-Salas E., Diez J., Villaverde A., Gebauer F., Rocha E., Dávila M., Domingo E. Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J Virol. 1988 Jun;62(6):2050–2058. doi: 10.1128/jvi.62.6.2050-2058.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES